Evaluation of “Programmed death-1”/”Programmed death ligand 1and 2” pathway in tumor samples of seminoma and non-seminoma, and its prognostic role in testicular cancers.


GARAYEV A., BOZKURTLAR E. , FİLİNTE D. , ÇAM H. K. , ŞİMŞEK F. , TİNAY İ.

AMERICAN UROLOGİCAL ASSSOCIATION ANNUAL MEETING 2017, 12 - 16 May 2017, vol.197, pp.1082

  • Publication Type: Conference Paper / Summary Text
  • Volume: 197
  • Page Numbers: pp.1082